# Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel®

> **NCT01145950** · PHASE1 · COMPLETED · sponsor: **LG Life Sciences** · enrollment: 36 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LBEC0101
- **DRUG:** Enbrel

## Key facts

- **NCT ID:** NCT01145950
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2010-11
- **Final completion:** 2011-01
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2011-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01145950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01145950, "Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel®". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01145950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*